ABSI ▼ -2.6% - Absci Corporation
$ABSI - Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
24-SEP-2026 08:00 AM ET
Share this post
More filings for $ABSI
ABSI ▼ -0.6% - Absci CorporationSep 8, 2026ABSI ▲ +0.2% - Absci CorporationSep 3, 2026ABSI ▼ -0.1% - Absci CorporationSep 1, 2026
View full $ABSI filing history →💬 Comments
Loading comments…
Leave a comment